Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
89bio | ETNB | Jun 14, 2024 | 8.77 | -5.60 |
Aligos Therapeutics | ALGS | Jun 14, 2024 | 0.50 | -1.59 |
ALX Oncology | ALXO | Jun 14, 2024 | 8.05 | -4.62 |
Annexon | ANNX | Jun 14, 2024 | 5.62 | -6.49 |
BioVie | BIVI | Jun 14, 2024 | 0.46 | -5.37 |
Cerevel Therapeutics | CERE | Jun 14, 2024 | 41.53 | -0.13 |
Chromadex | CDXC | Jun 14, 2024 | 2.98 | -6.88 |
Dyne Therapeutics | DYN | Jun 14, 2024 | 33.07 | -1.84 |
Exicure | XCUR | Jun 14, 2024 | 0.33 | -1.49 |
Fusion Pharmaceuticals | FUSN | Jun 14, 2024 | 21.55 | 0.00 |
Galapagos ADR | GLPG | Jun 14, 2024 | 25.44 | -1.09 |
Generation Bio | GBIO | Jun 14, 2024 | 2.74 | -19.88 |
Greenwich LifeSciences | GLSI | Jun 14, 2024 | 14.76 | -0.61 |
Inozyme Pharma | INZY | Jun 14, 2024 | 4.74 | -2.27 |
Inventiva ADR | IVA | Jun 14, 2024 | 2.97 | -6.01 |
iTeos Therapeutics | ITOS | Jun 14, 2024 | 16.23 | -0.43 |
Keros Therapeutics | KROS | Jun 14, 2024 | 49.36 | -0.28 |
Kintara Therapeutics | KTRA | Jun 14, 2024 | 0.18 | -1.98 |
Kronos Bio | KRON | Jun 14, 2024 | 1.08 | +1.89 |
Kymera Therapeutics | KYMR | Jun 14, 2024 | 33.29 | -4.53 |
Legend Biotech ADR | LEGN | Jun 14, 2024 | 42.45 | -2.79 |
Lyra Therapeutics | LYRA | Jun 14, 2024 | 0.30 | -4.80 |
Nautilus Biotechnology | NAUT | Jun 14, 2024 | 2.56 | -2.66 |
Nurix Therapeutics | NRIX | Jun 14, 2024 | 15.18 | -9.26 |
Nuvation Bio A | NUVB | Jun 14, 2024 | 3.02 | +1.00 |
Oric Pharmaceuticals | ORIC | Jun 14, 2024 | 7.49 | -2.47 |
PMV Pharmaceuticals | PMVP | Jun 14, 2024 | 1.67 | -4.02 |
Poseida Therapeutics | PSTX | Jun 14, 2024 | 2.76 | -3.16 |
Prelude Therapeutics | PRLD | Jun 14, 2024 | 3.90 | 0.00 |
Relay Therapeutics | RLAY | Jun 14, 2024 | 7.31 | -6.58 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.